EconomyA pharma giant has cleared one patent cliff, but another is looming
Disappointing data following a series of clinical trial setbacks underscores Novartis’ challenge in developing its next generation of blockbuster medicines.
C
CNBC★★☆☆☆2026-10-30 06:00Original
A pharma giant has cleared one patent cliff, but another is looming
Economy